BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28112502)

  • 1. Phase to Phase with TDP-43.
    Sun Y; Chakrabartty A
    Biochemistry; 2017 Feb; 56(6):809-823. PubMed ID: 28112502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.
    Mompeán M; Romano V; Pantoja-Uceda D; Stuani C; Baralle FE; Buratti E; Laurents DV
    J Biol Chem; 2017 Jul; 292(28):11992-12006. PubMed ID: 28566288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
    Vanden Broeck L; Callaerts P; Dermaut B
    Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
    Montalbano M; McAllen S; Cascio FL; Sengupta U; Garcia S; Bhatt N; Ellsworth A; Heidelman EA; Johnson OD; Doskocil S; Kayed R
    Neurobiol Dis; 2020 Dec; 146():105130. PubMed ID: 33065281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological phase transitions in ALS-FTD impair dynamic RNA-protein granules.
    Nedelsky NB; Taylor JP
    RNA; 2022 Jan; 28(1):97-113. PubMed ID: 34706979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy.
    Chen HJ; Topp SD; Hui HS; Zacco E; Katarya M; McLoughlin C; King A; Smith BN; Troakes C; Pastore A; Shaw CE
    Brain; 2019 Dec; 142(12):3753-3770. PubMed ID: 31605140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding proteins with prion-like domains in health and disease.
    Harrison AF; Shorter J
    Biochem J; 2017 Apr; 474(8):1417-1438. PubMed ID: 28389532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.
    French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM
    J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
    Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
    J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD.
    Pirie E; Oh CK; Zhang X; Han X; Cieplak P; Scott HR; Deal AK; Ghatak S; Martinez FJ; Yeo GW; Yates JR; Nakamura T; Lipton SA
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33692125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum.
    Baradaran-Heravi Y; Van Broeckhoven C; van der Zee J
    Neurobiol Dis; 2020 Feb; 134():104639. PubMed ID: 31626953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
    Chou CC; Zhang Y; Umoh ME; Vaughan SW; Lorenzini I; Liu F; Sayegh M; Donlin-Asp PG; Chen YH; Duong DM; Seyfried NT; Powers MA; Kukar T; Hales CM; Gearing M; Cairns NJ; Boylan KB; Dickson DW; Rademakers R; Zhang YJ; Petrucelli L; Sattler R; Zarnescu DC; Glass JD; Rossoll W
    Nat Neurosci; 2018 Feb; 21(2):228-239. PubMed ID: 29311743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RBM45 homo-oligomerization mediates association with ALS-linked proteins and stress granules.
    Li Y; Collins M; Geiser R; Bakkar N; Riascos D; Bowser R
    Sci Rep; 2015 Sep; 5():14262. PubMed ID: 26391765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
    Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
    Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R; Neumann M
    Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis/frontotemporal dementia.
    Sidibé H; Khalfallah Y; Xiao S; Gómez NB; Fakim H; Tank EMH; Di Tomasso G; Bareke E; Aulas A; McKeever PM; Melamed Z; Destroimaisons L; Deshaies JE; Zinman L; Parker JA; Legault P; Tétreault M; Barmada SJ; Robertson J; Vande Velde C
    Brain; 2021 Dec; 144(11):3461-3476. PubMed ID: 34115105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia.
    Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH
    J Neurol Sci; 2016 Jul; 366():197-201. PubMed ID: 27288806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis.
    van der Zee J; Dillen L; Baradaran-Heravi Y; Gossye H; Koçoğlu C; Cuyt I; Dermaut B; Sieben A; Baets J; De Jonghe P; Vandenberghe R; De Deyn P; Cras P; Engelborghs S; Van Broeckhoven C;
    Neurobiol Dis; 2021 Aug; 156():105421. PubMed ID: 34118419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death.
    Gasset-Rosa F; Lu S; Yu H; Chen C; Melamed Z; Guo L; Shorter J; Da Cruz S; Cleveland DW
    Neuron; 2019 Apr; 102(2):339-357.e7. PubMed ID: 30853299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Bright F; Chan G; van Hummel A; Ittner LM; Ke YD
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.